Design Therapeutics (DSGN) Gross Margin: 2020

Historic Gross Margin for Design Therapeutics (DSGN) over the last 1 years, with Dec 2020 value amounting to 100.00%.

  • Design Therapeutics' Gross Margin was N/A to 100.00% in Q4 2020 from the same period last year, while for Dec 2020 it was 100.00%, marking a year-over-year change of. This contributed to the annual value of 100.00% for FY2024, which is negligibly% changed negligibly from last year.
  • Design Therapeutics' Gross Margin amounted to 100.00% in Q4 2020, which was down 0.00% from 100.00% recorded in Q3 2020.
  • Design Therapeutics' Gross Margin's 5-year high stood at 100.00% during Q1 2020, with a 5-year trough of 100.00% in Q1 2020.
  • Its 1-year average for Gross Margin is 100.00%, with a median of 100.00% in 2020.